ProstACT Update: TARGET Study Ethics Approval
Go back to ProstACT Update: TARGET Study Ethics Approval| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 9.10 -0.41 (4.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.51 | 52 Week High | $2.18 | |||
| Open | $9.26 | 52 Week Low | $0.30 | |||
| Day High | $9.26 | P/E | N/A | |||
| Day Low | $8.98 | EPS | $-3.32 | |||
| Volume | 337,218 | |||||



